(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...
NHS patients across the UK are gaining faster access to life‑changing medicines and treatments, as new figures show the ...
India’s digital twin breakthroughs in healthcare—from AI lung models to cardiac and oncology simulations—are redefining ...
Her appointment accelerates Ailux's evolution from AI-native biologics discovery into a fully integrated drug development ...
It’s been a little over two months since President Donald Trump’s direct-to-consumer pharmaceutical site, TrumpRx, launched, ...
Dr James Fox explores the recent movements in the AstraZeneca share price and evaluates whether it's still a good long-term investment opportunity. The post What’s going on with the AstraZeneca share ...
Friday's positive trial results for tozorakimab mark a significant inflexion point for AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), ...
CT imaging has a key role to play in the management of patients with stable chronic obstructive pulmonary disease (COPD), said R. Graham Barr, MD, DrPH, in a presentation at the GOLD COPD ...
Dupixent drives a larger share of Sanofi's revenue, with atopic dermatitis (65%), asthma (20%), and CRSwNP (10%) as core indications; each faces varying competitive pressures. Revenue projections for ...
Introduction Elderly stable chronic obstructive pulmonary disease (COPD) patients frequently experience walking dysfunction. Research indicates that balance training holds promise for enhancing ...
New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are not only less harmful to the environment but can also lead to slightly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results